A collaboration with HIRF will ensure your organisation is part of an exciting new chapter in clinical imaging research. With cutting-edge scanning technology supplied by Siemens, HIRF has the potential to revolutionise patient care in the areas of dementia and ageing, mental illness, brain development and cancer.
There are three top reasons why HIRF is positioned for success:
Situated in Australia’s largest hospital precinct
HIRF is located at the heart of one our nation’s largest research and clinical precincts in close proximity to the Royal Brisbane and Women’s Hospital (RBWH) and partner research facilities such as The University of Queensland Centre for Clinical Research, QIMR Berghofer Medical Research Institute, and Queensland University of Technology’s Institute of Health and Biomedical Innovation.
Access to large patient cohorts for clinical trials
The RBWH is one of Australia’s largest quaternary and tertiary referral teaching hospitals with capacity for more than 900 beds and access to large patient cohorts for clinical trials in dementia, oncology and other conditions. In addition, the hospital houses a large, Good Manufacturing Practice (GMP) certified, radiochemistry facility producing the latest PET radio tracerswhich form the basis of imaging systems used at HIRF such as PET scans.
Support for early-phase clinical trials
HIRF is closely aligned to specialised contract research organisations that have extensive experience in supporting early phase clinical trials. Notable local organisations include Q-Pharm Pty Limited, which undertakes a broad range of early phase clinical trials for clients in the global pharmaceutical and biotechnology industries; and TetraQ, which provides GLP bioanalytical services to support preclinical studies as well as early phase clinical trials and bioequivalence studies in humans.
To find out how you can work with us to revoloutionise patient care, please contact: